LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_006231.4:c.2413C>T
POLE
· NP_006222.2:p.(Gln805Ter)
· NM_006231.4
GRCh37: chr12:133241943 G>A
·
GRCh38: chr12:132665357 G>A
Gene:
POLE
Transcript:
NM_006231.4
Final call
Likely Pathogenic
PVS1 very strong
PM2 moderate
Variant details
Gene
POLE
Transcript
NM_006231.4
Protein
NP_006222.2:p.(Gln805Ter)
gnomAD AF
ClinVar
Pathogenic
OncoKB
Unknown Oncogenic Effect
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PVS1 very strong: c.2413C>T creates the premature stop p.(Gln805Ter) in exon 21 of 49 with predicted nonsense-mediated decay, a null allele in a gene where biallelic loss of function causes FILS and IMAGe syndromes.
2
PM2 moderate: the variant is absent from every reporting population dataset (gnomAD-Canada v1.0 zero alleles; no gnomAD frequency), consistent with extreme rarity for a recessive-disease truncating allele.
Final determination:
The Leon-Castillo et al. 2020 custom POLE framework's likely-pathogenic combination rule 'PVS1_VeryStrong + 1 Moderate' is satisfied by PVS1 (very strong) together with PM2 (moderate), with no met benign criterion, yielding Likely Pathogenic under standard ACMG/AMP 2015 final-combination logic.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | Met | Met at Very Strong: c.2413C>T introduces premature stop p.(Gln805Ter) in exon 21 of 49 (MANE Select) with predicted NMD; biallelic POLE loss-of-function causes FILS/IMAGe syndromes. |
pvs1_variant_assessment
pvs1_gene_context
pvs1_generic_framework
vcep_path_250_323
PMID:23230001
PMID:25948378
PMID:30503519
gnomad_canada
|
| PS1 | N/A | Not applicable: p.(Gln805Ter) is a nonsense change, and no alternative nucleotide change can produce the same stop for PS1's same-amino-acid comparison. |
pvs1_variant_assessment
clinvar
pm5_candidates
|
| PS2 | Not assessed | Not assessed: no source reports c.2413C>T (p.Gln805Ter) as de novo, none of the three POLE papers mentions this variant, and no parental genotyping data exist. |
generic_acmg_combination_rules
clinvar
PMID:23230001
PMID:25948378
PMID:30503519
|
| PS3 | Not assessed | Not assessed: no well-established functional assay of p.Q805* exists - OncoKB lists no reviewed functional data and none of the three full-text papers mentions the variant. |
|
| PS4 | Not met | Not met: no case-control or recurrence enrichment exists for c.2413C>T; it falls outside the custom POLE PS4 set of exonuclease missense hotspots (COSMIC+TCGA count >=10). |
vcep_path_250_323
vcep_path_250_323_s002
clinvar
PMID:23230001
PMID:25948378
PMID:30503519
|
| PM1 | Not met | Not met: p.(Gln805Ter) is not a listed POLE exonuclease-domain hotspot substitution (framework residues 278-465), and no domain table or CancerHotspots signal places Q805 in a critical domain. |
final_classification_framework
vcep_path_250_323
|
| PM2 | Met | Met: c.2413C>T (p.Gln805Ter) is absent from gnomAD-Canada v1.0 and reported absent from gnomAD, supporting PM2 extreme rarity in population controls. |
gnomad_canada
clinvar
|
| PM3 | Not assessed | Not assessed: c.2413C>T (p.Gln805Ter) is reported nowhere in trans with a pathogenic POLE allele; the sole ClinVar submission and all three full-text papers lack proband phase data. |
generic_acmg_combination_rules
clinvar
PMID:23230001
PMID:25948378
PMID:30503519
|
| PM4 | N/A | Not applicable: PM4 covers in-frame deletions/insertions and stop-loss changes; this nonsense substitution p.(Gln805Ter) is a truncating null event adjudicated under PVS1. |
|
| PM5 | N/A | Not applicable: PM5 requires a novel missense change at a residue with a known pathogenic missense; p.(Gln805Ter) is a nonsense variant and no same-residue comparator exists. |
pvs1_variant_assessment
pm5_candidates
clinvar
|
| PM6 | Not assessed | Not assessed: no assumed-de novo occurrence of c.2413C>T (p.Gln805Ter) is reported anywhere, and proband-parental genotyping data for this variant are absent. |
generic_acmg_combination_rules
clinvar
PMID:23230001
PMID:25948378
PMID:30503519
|
| PP1 | Not assessed | Not assessed: no affected family members carrying c.2413C>T (p.Gln805Ter) are reported, so no segregating meioses exist to score for PP1. |
generic_acmg_combination_rules
clinvar
PMID:23230001
PMID:25948378
PMID:30503519
|
| PP2 | N/A | Not applicable: PP2 evaluates missense variants in genes where missense is a common mechanism; p.(Gln805Ter) is a truncating nonsense change, not missense. |
pvs1_variant_assessment
vcep_path_250_323
|
| PP3 | N/A | Not applicable: c.2413C>T is a nonsense change (p.Gln805Ter), and PP3 is calibrated only for missense or splice-region variants, not truncating ones. |
final_classification_framework
generic_acmg_combination_rules
|
| PP4 | Not assessed | Not assessed: no proband phenotype or family history is available, so specificity for a POLE-related disorder (FILS/IMAGe, biallelic loss-of-function) cannot be evaluated. |
clinvar
PMID:23230001
PMID:25948378
PMID:30503519
|
| PP5 | Not met | Not met: ClinVar holds a single one-star laboratory submission for c.2413C>T, and PP5 requires an exact-variant expert-panel Pathogenic/Likely pathogenic classification. |
clinvar
|
| BA1 | Not met | Not met: c.2413C>T is absent from every population dataset reporting an allele count (gnomAD-Canada v1.0), an allele frequency of zero far below the BA1 stand-alone threshold. |
gnomad_canada
clinvar
|
| BS1 | Not met | Not met: observed allele frequency is zero (absent from gnomAD-Canada v1.0; no gnomAD frequency), far below any frequency exceeding expectation for an ultra-rare recessive syndrome. |
gnomad_canada
clinvar
|
| BS2 | Not met | Not met: no healthy adult, homozygous or heterozygous, has been observed with c.2413C>T in any control or population dataset (absent from gnomAD-Canada v1.0). |
gnomad_canada
|
| BS3 | Not assessed | Not assessed: no functional assay data on p.Q805* in either direction; no validated study shows the variant preserves POLE function. |
|
| BS4 | Not assessed | Not assessed: no affected relatives have been genotyped for c.2413C>T (p.Gln805Ter), so absence of segregation (BS4) cannot be established or refuted. |
generic_acmg_combination_rules
clinvar
PMID:23230001
PMID:25948378
PMID:30503519
|
| BP1 | N/A | Not applicable: BP1 applies only to missense variants in primarily truncating genes; p.(Gln805Ter) is itself a truncating nonsense allele, and POLE missense is an established mechanism. |
pvs1_variant_assessment
vcep_path_250_323
PMID:23230001
PMID:25948378
PMID:30503519
|
| BP2 | Not assessed | Not assessed: no source reports c.2413C>T in cis (or trans for dominant disease) with a pathogenic POLE variant; heterozygous truncating-allele carriers are unaffected, so only cis-observation evidence could apply BP2. |
generic_acmg_combination_rules
clinvar
PMID:23230001
PMID:25948378
PMID:30503519
|
| BP3 | N/A | Not applicable: BP3 requires an in-frame indel in a repeat region without known function; c.2413C>T is a single-nucleotide nonsense substitution, not an indel. |
|
| BP4 | N/A | Not applicable: c.2413C>T is a nonsense change (p.Gln805Ter); BP4 likewise covers only missense or splice-region variants, never truncating ones. |
final_classification_framework
generic_acmg_combination_rules
|
| BP5 | Not assessed | Not assessed: no alternate molecular basis for disease was identified or documented for the proband, which BP5 requires. |
|
| BP6 | Not met | Not met: ClinVar has no expert-panel Benign/Likely benign classification for c.2413C>T; the sole one-star laboratory Pathogenic submission cannot trigger BP6. |
clinvar
|
| BP7 | N/A | Not applicable: BP7 is reserved for synonymous variants, but c.2413C>T creates a stop codon (p.Gln805Ter) instead. |
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.